Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion while Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion while breastfeeding. We will also discuss about common side effects and warnings associated with Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion.

What is Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion ?


helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Brief: Sunscreen

Can I use Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion while breastfeeding?

Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion high risk while breastfeeding
There are total 3 active ingredients in Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion which makes it a complicated task to assess the effect of Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion on breastfeeding. Here on drlact after analyzing all 3 ingredients we have reached on conclusion that Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion is unsafe in breastfeeding. Below is our summarized analysis of Avobenzone, Octinoxate, Octisalate.

Avobenzone and Breastfeeding

Safe

Not much study has been done on effects of topical usage of Avobenzone during breast feeding however it is known to penetrate the skin in very limited quantity. Its not very likely to have adverse effects in breastfed infants.

Note: Study and data for tropical use only, Breakdown product causes relatively high rates of skin allergy hence stabilization is required.

Warning: Tropical usage in breast area shall be avoided to prevent the Avobenzone passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Octisalate and Breastfeeding

Low Risk

Octyl salicylate is an oil soluble chemical sunscreen agent that absorbs UVB radiation. It does not protect against UVA. Octyl salicylate is used to augment the UVB protection in a sunscreen. Salicylates are weak UVB absorbers and they are generally used in combination with other UV filters

Octisalate rarely causes allergies in tropical usage. Not much study has been done on effects of topical usage of Octisalate during breast feeding however it is known to penetrate the skin hence it�s better to use other alternatives.

FDA study found blood levels 10 times above cutoff for systemic exposure, skin penetration in lab studies has been observed

Note: Study and data for tropical use only

Warning: Tropical usage in breast area shall be avoided to prevent the Octisalate passing orally in Infants.


What should I do if already breastfed my kid after using Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion usage and time interval of breastfeeding.


My doctor has prescribed me Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion then there must be good reason for that as Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Luminous Intensive Hand Treatment Spf 25 | Avobenzone, Octinoxate, And Octisalate Lotion in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients